F-star Therapeutics, Inc. (FSTX) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 32 transactions totaling $9.8K, demonstrating a bearish sentiment with -$9.8K in net insider flow. The most recent transaction on Mar 8, 2023 involved a transaction of 8,386 shares valued at $59.7K.
No significant insider buying has been recorded for FSTX in the recent period.
No significant insider selling has been recorded for FSTX in the recent period.
Based on recent SEC filings, insider sentiment for FSTX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$9.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at F-star Therapeutics, Inc. (FSTX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading FSTX stock, having executed 32 transactions in the past 90 days. The most active insider is Eliot Forster (Executive), who has made 5 transactions totaling $3.0M.
Get notified when executives and directors at FSTX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Arkowitz David | Executive | Tender | 8,386 | $7.12 | $59.7K | |
| Mar 8, 2023 | Benz Edward Jr | Executive | Disposition | 4,385 | $7.12 | $31.2K | |
| Mar 8, 2023 | Bermingham Nessan | Executive | Disposition | 6,328 | $7.12 | $45.1K | |
| Mar 8, 2023 | Bermingham Nessan | Executive | Tender | 97,547 | $7.12 | $694.5K | Large |
| Mar 8, 2023 | Race Geoffrey | Executive | Tender | 3,937 | $7.12 | $28.0K | |
| Mar 8, 2023 | Brewis Neil | Executive | Disposition | 9,375 | $7.12 | $66.8K | |
| Mar 8, 2023 | Brewis Neil | Executive | Tender | 105,088 | $7.12 | $748.2K | Large |
| Mar 8, 2023 | C. Brady Todd | Executive | Tender | 15,004 | $7.12 | $106.8K | |
| Mar 8, 2023 | M. Deptula-hicks Darlene | Executive | Tender | 30,898 | $7.12 | $220.0K | |
| Mar 8, 2023 | M. Deptula-hicks Darlene | Executive | Disposition | 25,539 | $7.12 | $181.8K | |
| Mar 8, 2023 | Forster Eliot | Executive | Tender | 347,578 | $7.12 | $2.5M | Large |
| Mar 8, 2023 | Forster Eliot | Executive | Disposition | 73,959 | $7.12 | $526.6K | Large |
| Mar 8, 2023 | Kayitalire Louis | Executive | Disposition | 25,019 | $7.12 | $178.1K | |
| Mar 8, 2023 | Kayitalire Louis | Executive | Tender | 29,236 | $7.12 | $208.2K | |
| Jul 29, 2022 | Race Geoffrey | Executive | Option Exercise | 3,937 | $0.11 | $433 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 8 | $4.5M | 80.8% |
Disposition(D) | 6 | $1.0M | 18.3% |
Exercise(M) | 3 | $37.6K | 0.7% |
Sale(S) | 4 | $9.8K | 0.2% |
Award(A) | 11 | $0 | 0.0% |
Insider selling pressure at F-star Therapeutics, Inc. has increased, with 9 insiders executing 32 transactions across all time. Total sales of $9.8K significantly outpace purchases of $0, resulting in a net outflow of $9.8K. This selling activity appears largely discretionary, which may warrant closer attention from investors.